Deep Tech Startups

Praxis is a first-check lead investor and co-creator focused on digital manufacturing businesses, backing and building companies in the manufacturing technology space. It works with founders as an early-stage investor and active board member.

1 investor

BUILT DNA manufactures synthetic DNA using its Regenerative DNA Assembly platform and a reusable fragment inventory, offering turnkey products such as clonal plasmid DNA, whole-plasmid synthesis, linear DNA templates, and pooled plasmid libraries. It serves researchers and innovators needing reliable DNA supply for applications including mRNA and saRNA production and high-throughput discovery.

1 investor

Sereact builds AI foundation models that enable industrial robots to perform complex manipulation tasks like warehouse picking and returns handling without retraining. The company operates a Robotics-as-a-Service model serving logistics, e-commerce, grocery, and automotive enterprises across Europe.

1 investor

Kue is an AI chatbot plugin for QGIS that translates plain English into SQL expressions and geoprocessing operations for geospatial analysis. It enables users to filter layers, perform complex geospatial tasks, and access OpenStreetMap data without writing code, trusted by 30+ governments worldwide.

1 investor

Buoyant Ventures is an early-stage venture fund that invests in seed and Series A companies developing AI, software, and hardware solutions for climate resilience, resource efficiency, and decarbonization. The firm operates primarily in the U.S. and Canada, providing capital and access to a network of executives from energy and industrial enterprises.

1 investor

Burnstar produces turquoise hydrogen using natural gas feedstock combined with carbon capture and storage technology to create zero-emission hydrogen for industrial and energy sector customers.

1 investor

Butterfly Ventures is a European venture capital firm committed to carbon-neutral operations, acquiring emission allowances to offset its annual carbon footprint while investing in early-stage startups. The firm focuses on funding companies developing meaningful innovations across sectors like healthcare, energy efficiency, and industrial technologies.

1 investor

Büyütech is a full-stack perception company that develops camera-based sensing technologies, combining hardware, imaging pipelines, edge AI, sensor fusion, and high-volume camera production. Its perception systems serve automotive, defense, and industrial mobility markets.

1 investor

MMT develops nondestructive testing instrumentation to measure mechanical properties of oil and gas pipelines without service interruption, using patented frictional sliding technology and AI modeling. The company serves pipeline operators and regulatory agencies seeking to extend infrastructure life while reducing testing costs and ensuring safety.

1 investor

Byorna develops a bioproduction platform that uses eukaryotic cell biofactories to manufacture high-quality messenger RNA (mRNA) at lower cost, isolating the mRNA in cellular subcompartments for extraction and GMP-grade production. Its technology targets mRNA-based therapeutics including vaccines for infectious diseases, cancer treatments, and RNA gene therapy for rare diseases.</parameter> <parameter name="founders">[]

1 investor

C-COM Satellite Systems designs and manufactures auto-pointing mobile satellite antenna systems, including its iNetVu vehicle-mount and flyaway terminals and portable Manpack antennas, providing satellite broadband connectivity in remote locations. It sells through a global dealer and integrator network to vertical markets such as cellular backhaul, disaster recovery, film production, and the military, and is developing next-generation electronically steerable flat-panel phased array antennas.

1 investor

C12 provides quantum computing strategy and preparation services, including a free cloud-based algorithm emulator and consulting engagements designed to help enterprises build quantum expertise and identify high-value use cases ahead of scalable hardware availability.

1 investor

C2MI is a research and development center for electronic systems, offering infrastructure and scientific equipment for microelectromechanical systems (MEMS), advanced semiconductor packaging, compound semiconductors, and printable electronics. It supports both small and large companies in developing microelectronic components from prototyping through commercialization across sectors such as aerospace, agriculture, communications, energy, quantum, and life sciences.

1 investor

Cachai develops collaborative autonomy software that converts hub-dependent systems into consensus-based distributed ones for mission-critical and defense applications. Its technology lets many devices operate as a coordinated swarm that divides tasks and adapts without a single point of failure.

1 investor

Caeli Nova develops respiratory physiology and oxygen-system technology to improve safety, performance and operational readiness for people operating in extreme environments, such as military fast jet aircrew. The company applies its combination of medical science and aerospace engineering primarily in the defence aerospace sector.

1 investor

CAGE Bio is a clinical-stage biotech developing localized topical treatments for dermatology, inflammation, and immunology conditions using its proprietary deep eutectic ionic liquid platform. The technology enables small and large molecules such as proteins and nucleic acids to penetrate the skin, aiming to match the efficacy of systemic drugs while avoiding their side effects.

1 investor

Calcarea develops nature-based solutions to decarbonize the economy, focusing on carbon capture and removal technologies. The company applies research in climate and oceanography to build commercial technologies for environmental impact.

1 investor

CALDRE is a Switzerland-based biotech spin-out developing liver-directed GalNAc-siRNA therapeutics, including its claudin-3 targeting candidate ClagalsiR, to restore bile flow and prevent fibrosis. It aims to treat cholestatic and fibrotic liver diseases such as primary sclerosing cholangitis and primary biliary cholangitis and reduce the need for liver transplantation.

1 investor

Calibrate Ventures is a seed-stage venture capital firm that invests in startups working on AI, automation, autonomy, machine learning, and robotics, partnering with technical founders at the earliest stages.

1 investor

Calmar Laser designs and manufactures ultrafast fiber lasers and fiber amplifiers for industrial, research, and academic use, with products built in-house at its Palo Alto facility. Its systems serve applications such as test and measurement, optical communications, biomedicine, multiphoton imaging, lidar, and micromachining, and it operates as an OEM supplier.

1 investor

Calycia Bioscience is a biotechnology company developing engineered macrophage cell therapies delivered locally into the brain to target aggressive solid tumors of the central nervous system. Its pipeline focuses on glioblastoma and melanoma brain metastasis within CNS oncology.

1 investor

Cambiotics develops a precision-formulated probiotic whose bacterial strains interact with PFAS ("forever chemicals") in the gut to support their removal from the body through the digestive system. Based on University of Cambridge research, it targets consumers exposed to PFAS, including first responders such as firefighters and military personnel, with a US product launch planned for 2026.

1 investor

Cambium is a venture capital firm that invests in and supports companies developing new computing paradigms. Its team has backgrounds as entrepreneurs, researchers, and investors focused on the development and commercialization of advanced computing technologies.

1 investor

Cambrian Works manufactures networking hardware, edge computing systems, and attachment technologies for satellites and space missions. The company provides routers, switches, and computers designed for inter-satellite communications and payload augmentation services in orbit.

1 investor